Ann Arbor, MI, United States of America

Sean Eddy

This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Life Technologies Corporation. Active years: 2018-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sean Eddy. Retrieved from https://idiyas.com/inventor/sean-eddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sean Eddy: Innovator in Cancer Research

Introduction

Sean Eddy is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research through his innovative work. With a total of 2 patents, Eddy is recognized for his advancements in understanding gene fusions and gene variants associated with cancer.

Latest Patents

Eddy's latest patents focus on gene fusions and gene variants that are linked to cancer. The disclosures provide valuable insights into gene fusions, gene variants, and novel associations with various disease states. Additionally, these patents include kits, probes, and methods for utilizing these discoveries in practical applications.

Career Highlights

Sean Eddy is currently employed at Life Technologies Corporation, where he continues to push the boundaries of cancer research. His work has been instrumental in developing new methodologies that enhance our understanding of genetic factors in cancer.

Collaborations

Eddy collaborates with notable colleagues, including Daniel Rhodes and Seth Sadis. Their combined expertise fosters a dynamic research environment that drives innovation in the field.

Conclusion

Sean Eddy's contributions to cancer research through his patents and collaborations highlight his role as a key innovator in the scientific community. His work continues to pave the way for advancements in understanding and treating cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…